Kazuya Nishii

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

Johannes Brägelmann, Carina Lorenz, Sven Borchmann et al. · Nature Communications · 2021 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer

Masashi Kawaraya, Kenichi Gemba, Hiroshi Ueoka et al. · British Journal of Cancer · 2003 · 54 citations · Full text

Medicine, Oncology, Pathology +14

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 39 citations

Medicine, Oncology, Pathology +14

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Satoru Senoo, Takashi Ninomiya, Go Makimoto et al. · Internal Medicine · 2018 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17